Diffuse intrinsic pontine glioma (DIPG) is a lethal pediatric brain cancer that often kills within a year of diagnosis. Now, researchers at Cold Spring Harbor Laboratory report they have developed a potential therapeutic for DIPG using antisense oligonucleotide (ASO) technology that lowered tumor growth and increased survival rates in mice.